Diagnostic Study of Patients With Stage I Testicular Cancer
Correlation of Histopathology, Immunohistochemistry and Quantitative Radiology With Outcome in Early Stage Nonseminomatous Germ Cell Tumor
Sponsor: Eastern Cooperative Oncology Group
Listed as NCT00003800, this NA trial focuses on Testicular Germ Cell Tumor and remains completed. Sponsored by Eastern Cooperative Oncology Group, it has been updated 7 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2023 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Nov 2017 — Jun 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Nov 2017 [monthly]
Unknown Status NA
First recorded
Nov 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eastern Cooperative Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .